NCT06085560

Brief Summary

The goal of this study is to improve use of colorectal cancer screening among screening eligible African Americans who are served by Federally Qualified Health Centers in Michigan. The main questions it aims to answer are:

  • To what extent to individual prefer and select to complete screening with colonoscopy versus stool-based (FIT Kit or sDNA) options?
  • Can full completion of (i.e. follow-through with) screening with a selected modality be enhanced by delivery of a culturally targeted intervention? Participants will learn about colonoscopy, FIT Kit and sDNA as recommended and widely used screening options. Participants will select a modality to complete their own screening with. Participants will then be randomized to one of three arms (usual care, standard intervention, culturally targeted intervention). Researchers will compare the extent to which intervention arms enhance completion rates across each of the three screening modalities.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable colorectal-cancer

Timeline
14mo left

Started Jul 2023

Typical duration for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Jul 2023Jun 2027

Study Start

First participant enrolled

July 12, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 17, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

3 years

First QC Date

October 10, 2023

Last Update Submit

September 9, 2025

Conditions

Keywords

Colorectal Cancer ScreeningColorectal CancerColonoscopyFIT KitsDNA KitCancer ScreeningHealth CommunicationHealth Disparities

Outcome Measures

Primary Outcomes (4)

  • Colorectal Cancer Screening Modality Request Rates

    Frequency (percentage) with which colonoscopy versus FIT Kit versus sDNA kit versus no screening are selected.

    up to 2 weeks

  • Colorectal Cancer Screening Completion Rate

    Frequency (percentage of time) that chosen screening method is fully completed.

    up to 6 months

  • Theory of Planned Behavior Colorectal Cancer Screening Outcomes

    Self-report measures of colorectal cancer screening attitudes, norms, perceived control, intentions to be screened are each adapted from published research (Lucas et al., 2021). These items are constructed following recommended procedures to ensure construct validity and adequate behavioral specificity (Fishbein \& Ajzen, 2011). All items use Likert-type scales that range from 1 (strongly agree) to 7 (strongly disagree).

    collected immediately, up to 1 hour

  • Anticipatory Racism

    Adapted from published research (Lucas et al., 2021), all participants respond to questions that asked whether they believe racism would impact the benefits they could experience from obtaining colorectal cancer screening. Participants will then respond to three questions that ask, "In some way, my obtaining CRC screening would be impacted by racism," "Racism would undermine the value of CRC screening for me." and "Racism would negatively impact the accuracy of my CRC screening. Responses are collected using a 7-point Likert-type scale that ranged from 1 (strongly agree) to 7 (strongly disagree).

    collected immediately, up to 1 hour

Study Arms (3)

Usual Care Message

ACTIVE COMPARATOR

Participants selecting a colorectal cancer screening will receive "usual care" from the FQHC.

Behavioral: Usual Care Message

Implementation Intention Intervention: Standard Message

ACTIVE COMPARATOR

Participants selecting a colorectal cancer screening will receive implementation intention messages in addition to the "usual care" from the FQHC.

Behavioral: Implementation Intention Intervention: Standard Message

Implementation Intention Intervention: Culturally-Targeted Message

EXPERIMENTAL

Participants selecting a colorectal cancer screening will receive culturally-targeted implementation intention messages in addition to the "usual care" from the FQHC.

Behavioral: Implementation Intention Intervention: Culturally-Targeted Message

Interventions

Usual care is provided by the FQHC for the screening option chosen.

Usual Care Message

Implementation Intention Intervention module includes standard messaging in addition to the usual care provided by the FQHC for the screening option chosen.

Implementation Intention Intervention: Standard Message

Implementation Intention Intervention module includes culturally-targeted framing of health information messages in addition to the usual care provided by the FQHC for the screening option chosen.

Implementation Intention Intervention: Culturally-Targeted Message

Eligibility Criteria

Age45 Years - 72 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • African American, ages 45-72, Medicaid or Medicare insurance, enrolled in a FQHC, eligible for CRC screening (Colonoscopy more than 10 years ago, Sigmoidoscopy more than 5 years ago, FOB test more than 1 year ago, FIT kit more than 1 year ago, sDNA test more than 3 years ago, Never been screened).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michigan State University

Flint, Michigan, 48502, United States

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be unaware of their assignment to usual care vs. intervention conditions
Purpose
SCREENING
Intervention Model
FACTORIAL
Model Details: Design is factorial. After watching a brief didactic video, participants who opt to partake in colorectal cancer screening self select one of three screening modalities (colonoscopy vs. FIT Kit vs. sDNA Kit). Participants are then randomly assigned to one of three study arms (usual care vs. implementation intentions intervention vs. culturally targeted implementation intentions intervention). Screening selection and study arms are fully crossed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
C.S. Mott Endowed Professor

Study Record Dates

First Submitted

October 10, 2023

First Posted

October 17, 2023

Study Start

July 12, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

September 16, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Data will be made available per requirements and sharing structures established by the American Cancer Society.

Shared Documents
STUDY PROTOCOL
Time Frame
Upon Study Completion

Locations